Advisor Group Holdings, Inc. Eye Point Pharmaceuticals, Inc. Transaction History
Advisor Group Holdings, Inc.
- $52.6 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,234 shares of EYPT stock, worth $41,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,234
Previous 6,808
52.5%
Holding current value
$41,783
Previous $64,000
53.13%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding EYPT
# of Institutions
164Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$108 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$87.9 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$87.9 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$57.1 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$55.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $440M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...